# Patrick Soon-Shiong

> Patrick Soon-Shiong is a Series A investor at Chan Soon-Shiong Family Foundation backing Health Care. See 20 investments, check sizes, portfolio. Updated Aug…

- Type: Angel Investor
- Fund: [Chan Soon-Shiong Family Foundation](https://shizune.co/investors/profile/chan-soon-shiong-family-foundation)
- Location: Los Angeles, United States
- Total investments: 20
- Last investment: Oct 2024
- Lead investor: 45%
- Last updated: Aug 2026
- X (Twitter): https://twitter.com/DrPatSoonShiong
- Website: https://x.com/DrPatrick
- Facebook: https://www.facebook.com/pages/Patrick-Soon-Shiong/111233005596330

Patrick Soon-Shiong is a Series A investor at Chan Soon-Shiong Family Foundation in Los Angeles focused on Health Care and Software. Patrick Soon-Shiong is the Executive Chairman of ImmunityBio. He previously worked at Wibbitz as a Board member. Patrick Soon-Shiong attended the University of the Witwatersrand.

## Round sizes

| Stage | Round size |
| --- | --- |
| Series A | $2M–$26M |
| Series B | $5M–$25M |
| Series C | $20M–$30M |

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Health Care | 5 | 25% |
| Software | 3 | 15% |
| SaaS | 2 | 10% |
| Energy | 2 | 10% |
| Internet | 2 | 10% |

41 industries tracked in total.

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 5 | 25% |
| Series B | 4 | 20% |
| Series C | 3 | 15% |
| Private Equity | 2 | 10% |
| Post-IPO Equity | 2 | 10% |

8 stages tracked in total.

### Country

| Country | Investments | Share |
| --- | --- | --- |
| United States | 14 | 70% |
| United Kingdom | 1 | 5% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Alyssum Therapeutics | Alyssum Therapeutics is a biotechnology company that focuses on developing next-generation immunotherapies to modulate B cells. | $26M | Series A | Oct 23, 2024 |  |
| Sienza Energy | Sienza Energy is developing a radical new approach to design and manufacture batteries. The company’s revolutionary strategy is based on a 3D nanotechnology electrode structure that takes advantage of advances in multiple fields over the last decade, providing an approach to battery design that is unique in the industry. By combining these advancesin an innovative way, Sienza can drastically improve the batteries’ energy and power densities — all with the goal of simultaneously reducing the overall battery costs. With this new approach, Sienza Energy can provide even more capability in a range of products, from smart devices to electric vehicles. |  | Series A | Feb 17, 2022 |  |
| Heliogen | Heliogen is a renewable energy technology company focused on eliminating the need for fossil fuels in heavy industry and powering a sustainable future. The company’s AI-enabled, modular concentrated solar technology aims to cost-effectively deliver near 24/7 carbon-free energy in the form of heat, power, or green hydrogen fuel at scale – forthe first time in history. Heliogen was created at Idealab, the leading technology incubator founded by Bill Gross in 1996. For more information about Heliogen, please visit heliogen.com. | $25M | Series A | Apr 08, 2020 |  |
| NantKwest | NantKwest is a clinical-stage immunotherapy company focused on harnessing the immune system to treat disease. It is a biotechnology company, engages in developing immunotherapeutic agents for various clinical conditions in the United States. The company’s product candidates include activated natural killer candidates for the treatment ofvirally-induced cancers, such as human papilloma virus-induced cervical, and head and neck cancers; ebola; and serious viral, fungal, and bacterial infections, as well as that is in Phase II clinical trials for the treatment of polyoma virus-induced merkel cell carcinoma. | $39M | Post-IPO Equity | Mar 26, 2019 |  |
| Directa Plus | Directa Plus is a nanotechnology company, manufactures nanoparticles. |  | Post-IPO Equity | Jan 30, 2019 |  |
| Heliogen | Heliogen is a renewable energy technology company focused on eliminating the need for fossil fuels in heavy industry and powering a sustainable future. The company’s AI-enabled, modular concentrated solar technology aims to cost-effectively deliver near 24/7 carbon-free energy in the form of heat, power, or green hydrogen fuel at scale – forthe first time in history. Heliogen was created at Idealab, the leading technology incubator founded by Bill Gross in 1996. For more information about Heliogen, please visit heliogen.com. | $10M | Series A | Oct 09, 2018 |  |
| PacketFabric | PacketFabric develops a next-generation networking platform to redefine network connectivity. It is a private layer 2 network as a service, providing scalable and secure connectivity between colocation facilities, to major cloud providers, and Internet Exchanges. PacketFabric is cost-effective and scalable network connectivity and all of itsservices are provided via the company's portal and API.PacketFabric was founded on 2015 and is headquartered in Culver City, California. | $25M | Series B | Jan 19, 2018 |  |
| Wibbitz | Wibbitz is an automated video creation company that empowers any team to produce professional short form video. The Wibbitz online platform makes it quick and easy to create video for social media, news & entertainment coverage, marketing, communications, recruitment, events and more. Creators have access to customizable video templates,drag-and-drop editing tools, a team of in-house experts, and millions of licensed photos, videos, and soundtracks. The Wibbitz Lightbox API solution enables video creation capabilities within any website or application to engage and retain users with video. Wibbitz powers video for leading brands including Bloomberg, Reuters, Bertelsmann, NBC Universal, HubSpot, and Birchbox. Wibbitz was founded in 2011 and has offices in New York City, Tel Aviv, Paris, and London. | $20M | Series C | Oct 23, 2017 |  |
| ImmunityBio | NantCel is an offshoot of Soon-Shiong's NantWorks conglomerate, developing molecular-level cell-based treatments for diseases. The company discovers and develop immunology based treatments for diseases through cell-based treatments at the molecular level. NantCell was formerly known as NantBioCell. It operates as a subsidiary of NantWorks. | $75M | Private Equity | Jun 02, 2015 |  |
| Wibbitz | Wibbitz is an automated video creation company that empowers any team to produce professional short form video. The Wibbitz online platform makes it quick and easy to create video for social media, news & entertainment coverage, marketing, communications, recruitment, events and more. Creators have access to customizable video templates,drag-and-drop editing tools, a team of in-house experts, and millions of licensed photos, videos, and soundtracks. The Wibbitz Lightbox API solution enables video creation capabilities within any website or application to engage and retain users with video. Wibbitz powers video for leading brands including Bloomberg, Reuters, Bertelsmann, NBC Universal, HubSpot, and Birchbox. Wibbitz was founded in 2011 and has offices in New York City, Tel Aviv, Paris, and London. | $8M | Series B | May 21, 2015 |  |

10 of 20 investments shown.

## Co-investors
- [Horizons Ventures](https://shizune.co/investors/profile/horizons-ventures) — VC Fund, 3 deals together
- [AME Cloud Ventures](https://shizune.co/investors/profile/ame-cloud-ventures) — VC Fund, 2 deals together
- [lool ventures](https://shizune.co/investors/profile/lool-ventures) — VC Fund, 2 deals together
- [Neotribe Ventures](https://shizune.co/investors/profile/neotribe-ventures) — VC Fund, 2 deals together
- [Qualcomm Ventures](https://shizune.co/investors/profile/qualcomm-ventures) — VC Fund, 2 deals together
- [Accel](https://shizune.co/investors/profile/accel) — VC Fund, 1 deal together

## About Chan Soon-Shiong Family Foundation

VC Fund · Los Angeles, United States

Chan Soon-Shiong Family Foundation focuses its grantmaking almost exclusively in the Los Angeles area to fund research.

1 contacts available at Chan Soon-Shiong Family Foundation.

| Name | Title | Profile |
| --- | --- | --- |
| Patrick Soon-Shiong | Chairman | https://shizune.co/investors/profile/patrick-soon-shiong |

## Similar investors

### Similar industry
- [Adam Nash](https://shizune.co/investors/profile/adam-nash) — Angel Investor
- [Dream Maker Ventures (DMV)](https://shizune.co/investors/profile/dream-maker-ventures-dmv) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

### Similar country
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [Right Side Capital Management](https://shizune.co/investors/profile/right-side-capital-management) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## Featured in investor lists
- [Energy Angel Investors](https://shizune.co/investors/energy-angel-investors)
- [Sustainability Angel Investors](https://shizune.co/investors/sustainability-angel-investors)
- [Impact Angel Investors](https://shizune.co/investors/impact-angel-investors)
- [Energy Angel Investors in United States](https://shizune.co/investors/energy-angel-investors-united-states)
- [Sustainability Angel Investors in United States](https://shizune.co/investors/sustainability-angel-investors-united-states)
- [Impact Angel Investors in United States](https://shizune.co/investors/impact-angel-investors-united-states)

## FAQ

### What does Patrick Soon-Shiong invest in?

Patrick Soon-Shiong invests primarily in Health Care, Software and SaaS startups, most often at Series A and Series B stage. Most of the 20 investments tracked by Shizune back companies in United States. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### What is Patrick Soon-Shiong's check size?

Patrick Soon-Shiong typically joins rounds of $2M–$26M at Series A, $5M–$25M at Series B and $20M–$30M at Series C. These ranges are 10th–90th percentile round sizes calculated from confirmed public funding rounds, so they are a realistic guide to the rounds Patrick Soon-Shiong participates in.

### When did Patrick Soon-Shiong last invest?

The most recent investment recorded for Patrick Soon-Shiong closed in Oct 2024. Shizune tracks 20 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co